吉妥珠单抗奥唑米星联合供体淋巴细胞输注成功治疗异基因干细胞移植后复发的急性髓系白血病。 - Suppr

Successful treatment with gemtuzumab ozogamicin and donor lymphocyte infusion for acute myeloid leukemia relapsing after allogeneic stem cell transplantation.

作者信息

Tachibana Takayoshi, Tanaka Masatsugu, Takasaki Hirotaka, Numata Ayumi, Fujisawa Shin, Maruta Atsuo, Harada Hiroshi, Mori Hiraku, Ishigatsubo Yoshiaki, Kanamori Heiwa

出版信息

Int J Hematol. 2011 Dec;94(6):580-2. doi: 10.1007/s12185-011-0967-8. Epub 2011 Dec 2.

DOI:10.1007/s12185-011-0967-8

PMID:22135078

Abstract

摘要

相似文献

Successful treatment with gemtuzumab ozogamicin and donor lymphocyte infusion for acute myeloid leukemia relapsing after allogeneic stem cell transplantation.

Int J Hematol. 2011 Dec;94(6):580-2. doi: 10.1007/s12185-011-0967-8. Epub 2011 Dec 2.

Treatment of relapsed acute myeloid leukemia with MLL/AF6 fusion after allogeneic hematopoietic stem cell transplantation with gemtuzumab ozogamicin with a long interval followed by donor lymphocyte infusion.

Leukemia. 2008 Jun;22(6):1273-4. doi: 10.1038/sj.leu.2405029. Epub 2007 Nov 8.

Cytoreduction with gemtuzumab ozogamicin and cytarabine prior to allogeneic stem cell transplant for relapsed/refractory acute myeloid leukemia.

Leuk Lymphoma. 2012 Oct;53(10):2085-8. doi: 10.3109/10428194.2011.603450. Epub 2011 Sep 6.

Preliminary results of the safety of immunotherapy with gemtuzumab ozogamicin following reduced intensity allogeneic stem cell transplant in children with CD33+ acute myeloid leukemia.

Clin Cancer Res. 2005 Oct 1;11(19 Pt 2):7164s-7170s. doi: 10.1158/1078-0432.CCR-1004-0018.

Gemtuzumab ozogamicin therapy for isolated extramedullary AML relapse after allogeneic hematopoietic stem-cell transplantation.

Tohoku J Exp Med. 2010 Feb;220(2):121-6. doi: 10.1620/tjem.220.121.

A Phase I Study of Reduced-Intensity Conditioning and Allogeneic Stem Cell Transplantation Followed by Dose Escalation of Targeted Consolidation Immunotherapy with Gemtuzumab Ozogamicin in Children and Adolescents with CD33+ Acute Myeloid Leukemia.

Biol Blood Marrow Transplant. 2016 Apr;22(4):698-704. doi: 10.1016/j.bbmt.2016.01.019. Epub 2016 Jan 16.

Haematological cancer: Gemtuzumab ozogamicin in acute myeloid leukaemia.

Nat Rev Clin Oncol. 2012 May 1;9(6):310-1. doi: 10.1038/nrclinonc.2012.83.

Autologous transplantation gives encouraging results for young adults with favorable-risk acute myeloid leukemia, but is not improved with gemtuzumab ozogamicin.

Blood. 2011 May 19;117(20):5306-13. doi: 10.1182/blood-2010-09-309229. Epub 2011 Mar 17.

Fractionated doses of gemtuzumab ozogamicin combined with 3 + 7 induction chemotherapy as salvage treatment for young patients with acute myeloid leukemia in first relapse.

Ann Hematol. 2012 Dec;91(12):1871-7. doi: 10.1007/s00277-012-1528-9. Epub 2012 Jul 21.

Successful treatment with gemtuzumab ozogamicin monotherapy in a pediatric patient with resistant relapse of acute myeloid leukemia.

Turk J Pediatr. 2009 Jan-Feb;51(1):69-71.

本文引用的文献

Azacitidine for treatment of imminent relapse in MDS or AML patients after allogeneic HSCT: results of the RELAZA trial.

Leukemia. 2012 Mar;26(3):381-9. doi: 10.1038/leu.2011.234. Epub 2011 Sep 2.

Gemtuzumab ozogamicin therapy for isolated extramedullary AML relapse after allogeneic hematopoietic stem-cell transplantation.

Tohoku J Exp Med. 2010 Feb;220(2):121-6. doi: 10.1620/tjem.220.121.

ASH evidence-based guidelines: is there a role for second allogeneic transplant after relapse?

Hematology Am Soc Hematol Educ Program. 2009:414-8. doi: 10.1182/asheducation-2009.1.414.

Gemtuzumab ozogamicin-induced long-term remission in a woman with acute myelomonocytic leukemia and bone marrow relapse following allogeneic transplantation.

Int J Hematol. 2009 Dec;90(5):643-647. doi: 10.1007/s12185-009-0440-0. Epub 2009 Nov 11.

Management of relapse after allo-SCT for AML and the role of second transplantation.

Bone Marrow Transplant. 2009 Dec;44(12):769-77. doi: 10.1038/bmt.2009.300. Epub 2009 Oct 26.

Leukemia. 2008 Jun;22(6):1273-4. doi: 10.1038/sj.leu.2405029. Epub 2007 Nov 8.

Outcomes among patients with recurrent high-risk hematologic malignancies after allogeneic hematopoietic cell transplantation.

Biol Blood Marrow Transplant. 2007 Oct;13(10):1160-8. doi: 10.1016/j.bbmt.2007.06.007. Epub 2007 Aug 3.

Gemtuzumab therapy for isolated extramedullary AML relapse following allogeneic stem-cell transplant.

Nat Clin Pract Oncol. 2007 Aug;4(8):491-5. doi: 10.1038/ncponc0899.

Final report of the efficacy and safety of gemtuzumab ozogamicin (Mylotarg) in patients with CD33-positive acute myeloid leukemia in first recurrence.

Cancer. 2005 Oct 1;104(7):1442-52. doi: 10.1002/cncr.21326.

Venocclusive disease of the liver after bone marrow transplantation: diagnosis, incidence, and predisposing factors.

Hepatology. 1984 Jan-Feb;4(1):116-22. doi: 10.1002/hep.1840040121.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Successful treatment with gemtuzumab ozogamicin and donor lymphocyte infusion for acute myeloid leukemia relapsing after allogeneic stem cell transplantation.

作者信息

出版信息

相似文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

本文引用的文献